Clinical Trial Update: Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)

View source ↗

Summary

This clinical trial update notes that a study evaluating kappa free light chains as biomarkers in multiple sclerosis and clinically isolated syndrome is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis

Snippet

Sponsor: Skripuletz, Thomas Prof. Dr. | Conditions: Multiple Sclerosis, Clinically Isolated Syndrome (CIS) | Status: ENROLLING_BY_INVITATION